Yasushi Otsuka, Ph.D., is a highly experienced professional in the pharmaceutical industry, currently serving as the Head of Japan Asset Leadership for Oncology at AbbVie since August 2025. Prior to this role, Yasushi Otsuka was a Global Program Team Lead and Japan Program Team Lead for Amyloidosis at Alexion Pharmaceuticals, Inc. from January 2021 to August 2025. Yasushi Otsuka's extensive tenure at Bristol Myers Squibb spanned from May 2003 to December 2020, where various positions included Director of Late Stage Oncology Development and Senior Manager of Clinical Research for Oncology. Beginnings in the industry were marked at CMIC Group and SmithKline Beecham Corporation in clinical monitoring and medical sales roles, respectively. Educationally, Yasushi Otsuka holds a Ph.D. and a Master's degree in Pharmaceutical Medicine from Kitasato University, complemented by a Bachelor of Engineering in Industrial Chemistry from Nihon University.
Previous companies
This person is not in the org chart
This person is not in any teams
This person is not in any offices